$エディソン・ネーション (BBIG.US)$ easy money

$エディソン・ネーション (BBIG.US)$
BINGO !!! thank you @The money maker for the recommendation

$NRXファーマシューティカルズ (NRXP.US)$
$Grove (GRVI.US)$
Day trade profit. thank you @The money makerfor recommendations

$Grove (GRVI.US)$ビンゴ！！！ありがとうございます @The money makerお勧めについて

$Grove (GRVI.US)$
Grove, Inc. (NASDAQ:GRVI) ("Grove" or the "Company"), a global innovator in hemp, health, and wellness, today announced the launch of Upexi, its wholly owned division to acquire promising Amazon and Ecommerce businesses.
Since 2020, funding has poured into Amazon aggregators, raising nearly $10 billion according to Marketplace Pulse. Investors are racing to fund these companies whose goals are to buy promising Amazon brands that buyers believe can be scaled. According to Marketplace Pulse, "The market had a breakout year in 2020 because of three factors: the pandemic accelerating spending on Amazon, Thrasio raising hundreds of millions of dollars, and Anker, an Amazon-native brand, going public." According to Bloomberg, Thrasio, having raised more than $2 billion, could see its IPO valued at more than $10 billion.
With the launch of Upexi, Grove intends to take direct aim at the Amazon Aggregation market. Grove plans to enter the market as a desirable suitor to which prospective business owners may sell. With Upexi, potential sellers will be able to access Grove's programmatic ad technology, in-house digital marketing experts, and direct partnership with a team of expert Amazon PPC buyers who fine tune listings or start from scratch.
Grove Inc. has made a name for itself in the CBD/cannabis space and has already begun expanding into other verticals. The company recently acquired Vitamedica, an online nutraceutical company, with a rapidly growing presence in ecommerce and Amazon. Through its in-house team of digital marketers, Grove is now pursuing more companies in health/wellness/beauty/pet care that they can take to the next level.
Grove's hemp business has fueled its growth up until this point, reporting 2021 fiscal year revenues, with key financial highlights:
$24.1 Million, a 250% Increase Over 2020
Net Earnings of $2.9 Million or $0.25 Per Share
4th Quarter revenues of $10.64 million a 361% growth over prior year quarter
Revenue guidance of $48-$55M for 2022

another 2 potential stock for today
$Hudson Capital (HUSN.US)$
$NRXファーマシューティカルズ (NRXP.US)$

昨日17ドルで売り抜けできて良かった。おかげで @The money maker買いと売りのターゲット
$ダットチャット・インク (DATS.US)$

今日は3つの取引可能な株があります
$スフィア3D・コーポ (ANY.US)$
$ランドケイディア・ホールディングス (WTRH.US)$
$Eスポーツ・エンターテイメント・グループ (GMBL.US)$

昨日は4つの潜在的な株を投稿しました。残念ながらWTRHを買わなかったので、売り目標の1.3ドルに達しました。ありがとうございました @The money makerソースのために
$ESS・テック・インク (GWH.US)$
$Biora Therapeutics (PROG.US)$
$エディソン・ネーション (BBIG.US)$